455 related articles for article (PubMed ID: 3274452)
21. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure.
Maddux MS; Veremis SA; Pollak R; Mozes MF
Transplant Proc; 1987 Feb; 19(1 Pt 3):2007-9. PubMed ID: 3079066
[TBL] [Abstract][Full Text] [Related]
22. Minnesota experience with 81 pancreas transplants since 1978.
Sutherland DE; Chinn PL; Goetz FC; Elick BA; Najarian JS
Transplant Proc; 1984 Jun; 16(3):695-703. PubMed ID: 6375036
[No Abstract] [Full Text] [Related]
23. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
[No Abstract] [Full Text] [Related]
24. Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.
Milgrom M; Kyriakides GK; Esquenazi V; Olson L; Miller J
Transplant Proc; 1987 Feb; 19(1 Pt 3):1873. PubMed ID: 3274444
[No Abstract] [Full Text] [Related]
25. Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors.
Gaber AO; Thistlethwaite JR; Haag BW; Stuart J; Mayes J; Fellner S; Stuart FP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1915-6. PubMed ID: 3274451
[No Abstract] [Full Text] [Related]
26. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
Cardella CJ; Harding ME; deVeber GA; Honey J; Cook GT
Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065
[No Abstract] [Full Text] [Related]
27. High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression.
Hiesse C; Neyrat N; Busson M; Bensadoun H; Lantz O; Bellamy J; Benoit G; Charpentier B; Fries D
Transplant Proc; 1990 Aug; 22(4):1909-10. PubMed ID: 2389483
[No Abstract] [Full Text] [Related]
28. A comparison of three immunosuppressive protocols in patients aged over 50 years.
Fryd DS; So SK; Kruse L; Canafax DM; Sutherland DE; Simmons RL; Najarian JS
Transplant Proc; 1987 Feb; 19(1 Pt 2):1530-1. PubMed ID: 3274374
[No Abstract] [Full Text] [Related]
29. Control of rejection of transplanted organs.
Keown PA; Stiller CR
Adv Intern Med; 1986; 31():17-46. PubMed ID: 3511616
[No Abstract] [Full Text] [Related]
30. Cyclosporin A as sole immunosuppressive agent for renal transplantation in children: effect on catch-up growth.
Hodson EM; Knight JF; Sheil AG; Roy LP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1687-92. PubMed ID: 2652553
[No Abstract] [Full Text] [Related]
31. Renal transplantation in older patients on peritoneal dialysis.
Cardella CJ; Harding ME; Abraham G; Robinson C; Oreopoulos D; Uldall PR; Jordan M; Cook G; Struthers N; Honey R
Transplant Proc; 1989 Feb; 21(1 Pt 2):2022-3. PubMed ID: 2652660
[No Abstract] [Full Text] [Related]
32. Prednisone used as treatment for rejection correlates with poor outcome.
Toussaint RM; Callender CO; Dunston GM; Flores J; Walters CS; John D; Yeager C; Bond O; Thompson C; Gear JC
Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
[No Abstract] [Full Text] [Related]
33. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
Simonton SC; Sibley RK; Fryd DS
Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
[No Abstract] [Full Text] [Related]
34. Prolonged cyclosporine therapy to induce solid engraftment after renal transplantation.
Weimar W; Versluis DJ; Wenting GJ; Derkx FH; Schalekamp MA; Jeekel J
Transplant Proc; 1987 Feb; 19(1 Pt 3):1998-9. PubMed ID: 3274462
[No Abstract] [Full Text] [Related]
35. Cardiac transplantation in the sixth decade of life.
Szentpetery S; Thames M; Hanrahan J; Morris J; Lower RR
Transplant Proc; 1987 Feb; 19(1 Pt 3):2492-4. PubMed ID: 3079089
[No Abstract] [Full Text] [Related]
36. Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy.
Canafax DM; Carleton BC; Matas AJ; Payne WD; Dunn DL; Sutherland DE; Najarian JS
Transplant Proc; 1993 Feb; 25(1 Pt 2):1692-3. PubMed ID: 8442239
[No Abstract] [Full Text] [Related]
37. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
[No Abstract] [Full Text] [Related]
38. Monotherapy with cyclosporine in kidney transplantation.
Andreu J; Campistol JM; Oppenheimer F; Ricart MJ; Vilardell J; Carretero P
Transplant Proc; 1990 Oct; 22(5):2270-1. PubMed ID: 2219364
[No Abstract] [Full Text] [Related]
39. Frequency of allograft renal vascular thrombosis under three immunosuppressive regimens at a single institution.
Gruber SA; Chavers B; Payne WD; Fryd DS; Canafax DM; Simmons RL; Najarian JS; Matas A
Transplant Proc; 1989 Feb; 21(1 Pt 2):2139-40. PubMed ID: 2652690
[No Abstract] [Full Text] [Related]
40. A flexible immunosuppression protocol for organ transplantation using cyclosporine, azathioprine, and prednisone.
Schweizer RT; Rovelli M; Roper L; Bartus SA
Transplant Proc; 1987 Feb; 19(1 Pt 3):1944-6. PubMed ID: 3079062
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
